Investor FAQ

Investor FAQ

Arcadia’s symbol on NASDAQ is RKDA.
Arcadia was founded in 2002.
Arcadia is headquartered in Dallas, Texas. Our address is:

5950 Sherry Lane
Dallas, TX 75225
Phone: (530) 756-7077
info@arcadiabio.com
Arcadia is a Delaware corporation.
Arcadia became a public company on May 15, 2015 and its IPO priced at $8.00 per share. The company is listed on NASDAQ as RKDA.
Arcadia does not offer a direct purchase program at this time.
Arcadia has a calendar year fiscal year. Its fiscal quarters are as follows: First Quarter: January 1 to March 31 Second Quarter: April 1 to June 30 Third Quarter: July 1 to September 30 Fourth Quarter: October 1 to December 31
Currently, Arcadia does not pay dividends, and hence does not offer a dividend reinvestment program.

Arcadia’s transfer agent is:

American Stock Transfer & Trust Company, LLC
(800) 937-5449 or (718) 921-8124
help@astfinancial.com
www.astfinancial.com
Arcadia’s auditor is Deloitte & Touche LLP.
Arcadia’s legal counsel is Weintraub Tobin.
As of December 31, 2022, we had 30 full-time employees.
Our corporate headquarters are located in Dallas, Texas, and we have an office in Sacramento, California.
All news releases can be accessed on Arcadia’s web site through the News & Events link.
Documents filed with the SEC can be accessed through the Investor Relations page of the Arcadia web site.
For further information, please contact us at info@arcadiabio.com.